» Articles » PMID: 10880551

Breast Density As a Predictor of Mammographic Detection: Comparison of Interval- and Screen-detected Cancers

Overview
Specialty Oncology
Date 2000 Jul 6
PMID 10880551
Citations 302
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Screening mammography is the best method to reduce mortality from breast cancer, yet some breast cancers cannot be detected by mammography. Cancers diagnosed after a negative mammogram are known as interval cancers. This study investigated whether mammographic breast density is related to the risk of interval cancer.

Methods: Subjects were selected from women participating in mammographic screening from 1988 through 1993 in a large health maintenance organization based in Seattle, WA. Women were eligible for the study if they had been diagnosed with a first primary invasive breast cancer within 24 months of a screening mammogram and before a subsequent one. Interval cancer case subjects (n = 149) were women whose breast cancer occurred after a negative or benign mammographic assessment. Screen-detected control subjects (n = 388) were diagnosed after a positive screening mammogram. One radiologist, who was blinded to cancer status, assessed breast density by use of the American College of Radiology Breast Imaging Reporting and Data System.

Results: Mammographic sensitivity (i.e., the ability of mammography to detect a cancer) was 80% among women with predominantly fatty breasts but just 30% in women with extremely dense breasts. The odds ratio (OR) for interval cancer among women with extremely dense breasts was 6.14 (95% confidence interval [CI] = 1.95-19.4), compared with women with extremely fatty breasts, after adjustment for age at index mammogram, menopausal status, use of hormone replacement therapy, and body mass index. When only those interval cancer cases confirmed by retrospective review of index mammograms were considered, the OR increased to 9.47 (95% CI = 2.78-32.3).

Conclusion: Mammographic breast density appears to be a major risk factor for interval cancer.

Citing Articles

Exploring MRI and Mammography Lesion Features for Breast Cancer Detection in PTEN Hamartoma Tumor Syndrome.

Hoxhaj A, Milants A, Techanithisawat P, Bult P, Hoogerbrugge N, Mann R Cancers (Basel). 2025; 17(5).

PMID: 40075703 PMC: 11899549. DOI: 10.3390/cancers17050856.


Screening of breast cancer in higher-risk Taiwanese women using contrast-enhanced mammography.

Chou C, Hong Y, Lin Y, Lin P Heliyon. 2025; 11(2):e41851.

PMID: 39897843 PMC: 11782981. DOI: 10.1016/j.heliyon.2025.e41851.


Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.

Nanaa M, Manavaki R, van Nijnatten T, Stranz N, Carriero S, Coleman W Eur Radiol. 2025; .

PMID: 39838090 DOI: 10.1007/s00330-024-11342-x.


Volumetric Breast Density Estimation From Three-Dimensional Reconstructed Digital Breast Tomosynthesis Images Using Deep Learning.

Ahluwalia V, Doiphode N, Mankowski W, Cohen E, Pati S, Pantalone L JCO Clin Cancer Inform. 2024; 8():e2400103.

PMID: 39652797 PMC: 11643139. DOI: 10.1200/CCI.24.00103.


Association between mammographic breast density and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy.

Rella R, Belli P, Romanucci G, Bufi E, Clauser P, Masiello V Breast Cancer Res Treat. 2024; 210(1):157-166.

PMID: 39531133 DOI: 10.1007/s10549-024-07548-8.